Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?

Detalles Bibliográficos
Autor principal: Manzo, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369280/
https://www.ncbi.nlm.nih.gov/pubmed/34447920
http://dx.doi.org/10.31138/mjr.32.2.186
_version_ 1783739259863171072
author Manzo, Ciro
author_facet Manzo, Ciro
author_sort Manzo, Ciro
collection PubMed
description
format Online
Article
Text
id pubmed-8369280
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Mediterranean Journal of Rheumatology (MJR)
record_format MEDLINE/PubMed
spelling pubmed-83692802021-08-25 Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other? Manzo, Ciro Mediterr J Rheumatol Letter to the Editor The Mediterranean Journal of Rheumatology (MJR) 2021-06-30 /pmc/articles/PMC8369280/ /pubmed/34447920 http://dx.doi.org/10.31138/mjr.32.2.186 Text en © 2021 The Mediterranean Journal of Rheumatology (MJR) https://creativecommons.org/licenses/by/4.0/This work is licensed under and Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Letter to the Editor
Manzo, Ciro
Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
title Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
title_full Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
title_fullStr Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
title_full_unstemmed Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
title_short Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
title_sort rheumatic immuno-related adverse events following immunotherapy with checkpoint inhibitors: adverse drug reaction, or other?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369280/
https://www.ncbi.nlm.nih.gov/pubmed/34447920
http://dx.doi.org/10.31138/mjr.32.2.186
work_keys_str_mv AT manzociro rheumaticimmunorelatedadverseeventsfollowingimmunotherapywithcheckpointinhibitorsadversedrugreactionorother

Ejemplares similares